New online tool aims to keep cancer survivors on track with Follow-Up care
NCT ID NCT05346796
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests an online portal called SCP-PHR designed to help colon and rectal cancer survivors manage their survivorship care. Researchers will enroll 250 adults who have completed initial treatment within the past year. The goal is to see if the portal improves how often survivors get recommended surveillance tests and preventive care.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Survivorship Care Plan-Personal Health Record (SCP-PHR) online portal
- What this could lead to
- If successful, this could provide a practical tool to help cancer survivors stay on track with recommended follow-up tests and preventive care.
- What could go wrong
- This is a behavioral intervention study, not a drug trial. The tool may not significantly improve outcomes, and results depend on patient engagement and internet access.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indiana University School of Medicine
RECRUITINGIndianapolis, Indiana, 46202, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Could sitting up make radiation therapy more comfortable?
- Can we predict chemo brain before it happens?
- Can we predict dangerous side effects when combining radiation and immunotherapy?